DNA vaccine to prevent Yellow Fever

Project 47

Problem to be solved:
• Restrictions on the use of commercial vaccine on populations at risk
• Limitations in the production process
• Chance of developing side effects and allergies

Proposed Innovation:
• DNA vaccine against yellow fever
• Reduction in severe side effects
• Easy implementation of large-scale production

Differential:
• Stability at room temperature
• Longer shelf life
• No necessity of chemical preservatives or additives
• Noninfectious, offering higher biosafety

Development status:
Prototype

Intellectual property status:
BRPI0905645-9 (corresponding PCT filed)

Technology transfer status:
Prospecting partnership

Coordinator:
Ernesto Marques / CPqAM

Contact:
Gestec/VPPIS – Phone: 21 3882-9099 / 3882-9120 or portfolio@fiocruz.br